|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Call for abstracts - 7th World COGIFrom: OBGYN.net Update (newsletter@obgyn.net)Thu Feb 3 12:31:28 2005
The 7th World Congress on Controversies in Obstetrics, Gynecology & InfertilityIf you are unable to read HTML emails, please click here: http://www.obgyn.net/COGI7/020305.html The Congress has an informative homepage where you may find the, scientific program, registration form, hotel information and CME. Please note that the deadline for submission for poster presentation is February 10, 2005. To submit an abstract please visit:http://obgyn.net/ads/url.cfm?http://www.kenes.com/controversies/cogi7/call.asp . The early Registration deadline is February 15, 2005 . Following this message you will be able to view the whole scientific program. We look forward to welcoming you in Athens in April Zion Ben Rafael George Creatsas Zeev Shoham Scientific Program: Obstetrics, Gynecology and Infertility A. Infertility and ART Friday, April 15, 2005 08:00 - 09:45 Gamete Cryopreservation Capsule: Do we need more experience to decide that it does not work? Chairperson: S.L. Tan, Canada 1.. Ovarian freezing - are we progressing? What are the gaps? M. Sanchez, Spain 2.. First Pregnancy after orthotopic transplantation of cryopreserved ovarian tissue J. Donnez, Belgium 3.. Oocytes cryopreservation - can we increase the success? L. Hägglund, Sweden 4.. Round table discussion: What should we recommend to our patients? 09:45 - 11:15 Stem Cells Capsule: Are we stepping into the dark? Can we differentiate between the risks and the benefits? Chairperson: J. Cohen, France 1.. Cloned human embryonic stem cells and its potential application W-S. Hwang, Korea 2.. Technical aspects of establishment of human embryonic stem cells by somatic cell nuclear transfer S.K Kang, Korea 3.. Human embryonic stem cells- potential applications for regenerative and reproductive medicine B. Reubinoff, Israel 11:15 - 11:45 Coffee Break 11:45 - 13:00 Snakes, Bugs and Us S. Granai, USA 13:00 - 14:00 Lunch Break 14:00 - 16:00 IVF or Surgery First? Capsule: Female reproductive tract pathology limits the results of ART. Can we choose when to operate first and when to postpone and do IVF? Chairpersons: V. Gomel, Canada, S. Corson, USA 1.. Fibroid or IVF- which comes first? A. Arici, USA 2.. Treatment of tubal pathology or IVF J. Bontis, Greece 3.. Endometrioma: IVF or laparoscopy - which comes first? 4.. Resection of uterine septum or IVF - which comes first? J. Donnez, Belgium 16:00 - 16:30 Coffee Break 16:30 - 18:00 Risks of Ovarian Stimulation Capsule: Can we differentiate the time risk of this common procedure? Chairpersons: A. Pellicer, Spain, Z. Shoham, Israel 1.. Induction of ovulation and ovarian cancer: is the issue still controversial? C. W. Burger, The Netherlands 2.. Is endometrial receptivity altered in COH cycles? 3.. Increased risks of health problems in singleton ART babies: is it the IVF procedure, the ovarian stimulation or the infertility itself? J. Cohen, France 18:00 - 19:00 Hot Controversies 1.. Could we treat PCOS women with no infertility problems? L. Pawelczyk, Poland 2.. Is there a place for CC in the treatment of the infertile couple? A. Weissman, Israel 3.. Fresh ovarian tissue transplant: a proposal of a place to implant it L. H. Sordia, Mexico 4.. Literature review: to assess the efficacy of metformin in the clomiphene resistant patients T. I. Siebert, South Africa Saturday, April 16, 2005 08:00 - 09:30 Pollution, Infertility and Carcinogenesis Capsule: The role of endocrine disrupting agents in the pathogenesis of male and female infertility, and carcinogenesis is poorly understood, what the gynecologist should know and what possible strategies exist to counteract such effects. Chairpersons: F. Comhaire, Belgium, J. Cohen, France 1.. Ecological aspects of environmental pollution: Focusing on carcinogenesis P. Nicolopoulou, Greece 2.. Other health hazards of hormone disrupters and how to fight them. F. Comhaire, Belgium 3.. Impact of the environment on reproductive health: a bitter lesson for Athens D.A. Adamopoulos, Greece 09:30 - 10:00 Coffee Break 10:00 - 12:00 Ovarian Stimulation Capsule: The most crucial step in IVF was never less controversial Chairpersons: B. Tarlatzis, Greece, Z. Ben-Rafael, Israel 1.. Is there an evidence-based preferred protocol for ART? A. Pellicer, Spain 2.. GnRH antagonists an unfulfilled expectation? P. Barri, Italy 3.. Induction of monoovulatory cycles for ART P. Crosignani, Italy 4.. Functional hypothalamic amenorrhea: a neuroendocrine based defensive mechanism A.D. Genazzani, Italy 12:00 - 12:30 Special lecture supported by Medison: The clinical advantages of 3D extended imaging in Ob/Gyn G. Nazzaro, Italy 12:30 - 13:30 Lunch Break 13:30 - 15:30 PCOS Capsule: Are we coming closer to understanding and treating this common endocrinopathy? Chairperson: S. Daya, Canada 1.. Risks of COH Z. Ben-Rafael, Israel 2.. Why do we need LH if pure FSH works? 3.. Over weight women: pro-fertility effect of weight reduction P. Crosignani, Italy 4.. Do we need insulin sensitizers? B. Tarlatzis, Greece 15:30 - 16:00 Coffee Break 16:00 - 17:30 In-Vitro Maturation Capsule: Can this new technique develop to be an important alternative? 1.. IVM - Can we improve the results by priming with FSH and HCG? Endometrial impact A. Lis Mikkelsen, Denmark 2.. IVM as an alternative in poor and over responders S.L. Tan, Canada 3.. Do children born after IVM develop normally? A. Lis Mikkelsen, Denmark 17:30 - 19:00 Hot Controversies Chairperson: E. Margalioth, Israel 1.. Treatment of patients with repeated IVF failures E. Margalioth, Israel 2.. Is there a life for IUI after the advent of ICSI? M. Yemini, USA 3.. Does PGD help in improving results in patients with repeated IVF failure? G. Maroulis, Greece 4.. The relationship between acrosome activity of human spermatozoa and oxidative stress A.H. Ahmed, Egypt 5.. Factors affecting frozen embryo transfer program H. A. Hashim, Saudi Arabia 6.. The use of advanced reproductive technologies in Israel: are the professional partners seeing eye to eye? B. Kaplan, Israel 7.. Review of non-surgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with PCOS A.M. Saleh, Saudi Arabia 8.. The peritoneal fluid. A cause or a consequence of endometriosis? J. Szamatowicz, Poland Sunday, April 17, 2005 08:00- 09:30 Prevention of Pregnancy Failures in IVF Capsule: Can we increase the success? Can we decrease miscarriage rate in IVF? Chairpersons: P. Crosignani, Italy, A. Arici, USA 1.. The use of aspirin and adjuvant therapy in ART S. Daya, Canada 2.. Prevention of multiple gestation attributable to IVF/ICSI D. Loutradis, Greece 3.. Can PGD overcome recurrent pregnancy failure? Yes L. Gianaroli, Italy 09:30 - 10:00 Coffee Break 10:00 - 11:30 Embryo Transfer Capsule: The most crucial step of IVF is replacement and implantation. Are we doing something wrong? Chairperson: G. Grudzinskas, UK 1.. New aspects of luteal phase treatment A. Hazout, France 2.. Luteal phase support in ART S. Daya, Canada 3.. Selection of embryo for transfer after genetic investigation- is it safe? Is it cost effective? L. Gianaroli, Italy 11:30 - 13:00 New Technology and Techniques Chairpersons: G. Grudzinskas, UK, T. Gurgan, Turkey 1.. Virtual hysteroscopy to submucosal myomas T. Akaeda, Japan 2.. No more need for hysterosalpingogram to diagnose uterine anomalies: we now have 3D ultrasound I. Timor Trish, USA 3.. Immunology testing in fertility practice - truth or deception? A. Arici, USA B. Gynecology /Menopause and Family Planning Friday, April 15, 2005 08:00 - 09:45 Sexual Dysfunction Capsule: Sexual dysfunction remains a major problem in females but not in men Chairpersons: M. Legato, USA, A. Genazzani, Italy 1.. Sexual dysfunction in men and women. 2.. Male sexual dysfunction what are the options 3.. Androgen deficiency syndrome in women - does it exist? Fiction or reality? G. Mastorakos, Greece 09:45 - 11:15 Surgical Practice Chairpersons: P.E. Schwartz, USA, T. Paszkowski, Poland 1.. The ten steps vaginal hysterectomy - "less is more" M. Stark, Germany 2.. Hysterectomy: should we really remove the cervix? J. Donnez, Belgium 3.. Complications of operative laparoscopy V. Gomel, Canada 11:15 - 11:45 Coffee Break 11:45 - 13:00 Snakes, Bugs and Us Skip Granai, USA 13:00 - 14:00 Lunch Break 14:00 - 16:00 Non-Hormonal Treatment of Menometrorrhagia Chairpersons: S. Corson, USA, J. Donnez, Belgium 1.. The evolution of the Thermachoice Device S. Corson, USA 2.. Ablation - what can be expected after 3 years? F. Loffer, USA 3.. Combined essure sterilization and ablation R. Zurawin, USA 4.. Combined myomectomy and simultaneous ablation F. Loffer, USA 16:00 - 16:30 Coffee Break 16:30 - 18:00 Laparoscopic Oncology Capsule: Laparoscopy is a potent tool but the debate over safety and indications in patents with gynaecological cancer is still on Chairpersons: F. Nezhat, USA, P. Schwartz, USA 18:00 - 19:00 Hot Controversies Chairperson: R. Zurawin, USA 1.. A new safer bipolar intelligent coagulation system C. Wallwiener, Germany 2.. Uterine artery embolization in the treatment of hemorrhage in obstetrics and gynecology J. Kotarski, Poland 3.. In vivo proton magnetic resonance spectroscopy: a new non-invasive discriminatory test for ovarian tumor? E. A. Boss, The Netherlands 4.. Choriocarcinoma - Ultrasonographic models B. S. Nikolic, Yugoslavia Saturday, April 16, 2005 08:30- 09:30 Screening and Treatment of Ovarian Cancer Capsule: Is delayed diagnosis of ovarian cancer the major problem affecting prognosis? Chairperson: F. Nezhat, USA 1.. Prophylactic oophorectomy, salpingectomy and omentectomy in BRCA carriers with or without hysterectomy P. E. Schwartz, USA 2.. The same or not? Eight things changing Gyn-oncology C. Granai, USA 3.. Lymph node sampling - is it a waste of time? S. Fotiou, Greece 09:30 - 10:00 Coffee Break 10:00 - 12:00 WHI- What’s Next Capsule: WHI resulted in a major impact of menopausal care - is the shadow vanishing? 1.. HT and heart disease: Is it still an unsettled issue? G. Christodoulakos, Greece 2.. Is HT still first-line therapy for postmenopausal osteoporosis prevention? J. C. Stevenson, UK 3.. The Million Women Study - what is the critique? R. Farmer, UK 4.. HT: is it a risk or a benefit? J. C. Stevenson, UK 12:00 - 12:30 Special Lecture: The clinical advantages of 3D extended imaging in Ob/Gyn G. Nazzaro, Italy 12:00 - 13:30 Lunch Break 13:30 - 15:30 Family Planning endorsed by the Tarnesby Chair of Fertility Regulation Capsule: What are the advantages of the new methods of family planning? Chairpersons: A. Volpe, Italy, L. Farmer, UK 1.. Newer progestogens. Progesterone-only pill. Do they offer any advantage? S. Rozenberg, Belgium 2.. Prolonged use of OCs for symptomatic women P. G. Crosignani, Italy 3.. Adolescent contraception: Is there one solution? G. Creatsas, Greece 4.. Nuva ring 15:30 - 16:00 Coffee Break 16:00- 17:30 Hormonal Treatment for Males and Females Capsule: Do we have to change our prescribing habits in females? Do we have to treat males? Chairperson: J. C. Stevenson, UK 1.. Hormone therapy: what are the guidelines for HT in men and women? M. Legato, USA 2.. Hormone replacement therapy in the male and nutriceutical alternatives F. Comhaire, Belgium 3.. Hormonal therapy effect on brain and quality of life A. R. Genazzani, Italy 17:30 - 19:00 Hot Controversies 1.. Oophorectomy using hysterectomy - at what age? The special case of endometriosis A. Schindler, Germany 2.. Endometrial biopsy vs. transvaginal sonography as a first line in patients with pathologically proven endometrial polyps J. Lerner, USA 3.. Transvaginal temporary uterine artery occlusion for the treatment of symptomatic leiomyomas G. A. Vilos, Canada 4.. Is sonography useful for early detection of reproductive tract cancer? M. Spaczynski, Poland 5.. HIV infections in women - how to deal with them? T. Niemiec, Poland 6.. Vaccination as alternative to hormonal replacement therapy M. Corocleanu, Romania Sunday, April 17, 2005 08:00 - 09:30 Gender Based Medicine Capsule: Differences between genders exist in almost every aspect. What do we know about these differences? Chairperson: J. C. Stevenson, UK 1.. What is Gender medicine? Should we care? M. Legato, USA 2.. Sleep disturbances - why women are different to men? Y. Dagan, Israel 3.. Gender-specific features of the experience of coronary artery disease. M. Legato, USA 09:30 - 10:00 Coffee Break 10:00 - 11:30 Urogynecology Capsule: Innovative solutions offer further treatment to this gender specific problem Chairpersons: N-O. Sjoberg, Sweden, S. Stanton, UK 1.. Midurethral tapes - which one? S. Stanton, UK 2.. Can USI be treated medically? How to treat A. Liapis, Greece 3.. Prolapse repair; mesh or not? S. Stanton, UK 11:30 - 13:00 Endoscopy Session Capsule: Endoscopy - did it reach its limitation? Chairperson: V. Gomel, Canada 1.. The role of robotic surgery in gynecology T. Falcone, USA 2.. Laparoscopic Hysterectomy - why is it not more popular? G. Pantos, Greece 3.. Complications of laparoscopic surgery- can they ever be eliminated? T. Falcone, USA C. Perinatology and Prenatal diagnosis Friday, April 15, 2005 08:00 - 09:45 High and Low-Risk Pregnancies Capsule: There is confusion about incidence and risk to the fetus Chairperson: G. C. Di Renzo, Italy 1.. Is there an optimal rate for CS? S. Chasen, USA 2.. CS to all twins I. Blickstein, Israel 3.. Is there a place for electronic monitoring in the low risk patients? What are the consequences? J. Gardosi, UK 4.. Antepartum fetal evaluation in diabetic pregnancies A. M. Vintzileos, USA 09:45 - 11:15 Second Trimester Miscarriage Capsule: Late abortion is mainly due to anatomical and mechanical problems Chairperson: J. Gardosi, UK 1.. Pregnancy loss: Evaluation and treatment A. M. Vintzileos, USA 2.. The role for emergency cerclage - when? Until which week? K. Nicolaides, UK 3.. The value of 3D ultrasound in the evaluation of uterine anomalies G. Nazzaro, Italy 11:15 - 11:45 Coffee Break 11:45 - 13:00 Snakes, Bugs and Us S. Granai, USA 13:00 - 14:00 Lunch Break 14:00 - 16:00 Clinical Controversies in the Management of Preterm Labour Capsule: Preterm labour is a major risk factor for prematurity. Can we accurately diagnose and treat it? Chairperson: G. C. Di Renzo, Italy 1.. Tocolysis efficacy - what is the evidence? K. Khan, UK 2.. Ethical controversies in the management of preterm labour 3.. Case studies of unresolved issues in preterm birth: a multidisciplinary review Moderator: G. C. Di Renzo Panel: A. M. Vintzileos, USA 16:00 - 16:30 Coffee Break 16:30 - 18:30 Fetal Growth: Implication for Perinatal Care Capsule: What are the most appropriate strategies for preventing complications due to growth problems? Chairpersons: J. Gardosi, UK, B. Jacobsson, Sweden 1.. IUGR and perinatal mortality J. Gardosi, UK 2.. IUGR and cerebral palsy B. Jacobsson, Sweden 3.. Fetal growth in twins S. Kady, UK 4.. Evidence based assessment J. Gardosi, UK 18:00 - 19:00 Hot Controversies 1.. Performances of Dinoprostone in the elective induction of labor for advanced gestational age (>286 days) F. Facchinetti, Italy 2.. Use of B-Lynch suture technique for postpartum hemorrhage- a case report and review of the literature B. Vijayalakshmi, UK 3.. Modified compression suture for the treatment of intractable postpartum hemorrhage: experience with 18 cases T. Tran Son, Vietnam 4.. The laparoscopy in pregnant women - what is its role? M. Klimek, Poland Saturday, April 16, 2005 08:00 - 09:30 Pre-eclampsia Capsule: The debate continues. Can we decrease mortality and morbidity in eclampsia? 1.. How to classify when to deliver? C. Sen, Turkey 2.. Should we screen pre-eclampsia? What for? A. Antsaklis, Greece 3.. The place of MgSO4 therapy for prophylaxis and in which cases G. C. Di Renzo, Italy 4.. The mode delivery and analgesia in pre-eclampsia T. Sener, Turkey 09:30 - 10:00 Coffee Break 10:00 - 12:00 Contemporary Management of Hyperprolactinaemia: Issues and Intervention Capsule: Contemporary management of hyperprolactinaemia: are all the issues settled? 1.. Understanding the aetiology and evaluation of hyperprolactinaemia 2.. Clinical implications of hyperprolactinaemia in the short and long-term 3.. The benefits and challenges of dopamine agonist therapy in the treatment of hyperprolactinaemia 12:00 - 12:30 Special Lecture sponsored by Medison: The clinical advantages of 3D extended imaging in Ob/Gyn G. Nazzaro, Italy 12:30 - 13:30 Lunch Break 13:30 - 15:30 Prenatal Screening and Diagnosis Capsule: There is still no agreed policy on how best to screen for anomalies Chairperson: A.M. Vintzileos, USA 1.. Prenatal screening is best done in the first trimester, “18 week” anatomy scan: useless waste of time and money! I. E. Timor-Trish, USA 2.. 11-14 week nuchal translucency scan can be combined with a structural fetal ultrasound? K. Nicolaides, UK 3.. 3D / 4: scan for parental entertainment or contribution to anomaly detection? N. Vrachnis, Greece 4.. The ethical issues of first trimester screening S. Chasen, USA Roundtable discussion: Can 11-14 week nuchal translucency scan be combined with a structural fetal ultrasound? 15:30 - 16:00 Coffee break 16:00 - 17:30 Breast Cancer Capsule: Recent confusion began over the benefits of mammography screening in detecting cancer before a lump is detectable during physical examination. Should annual mammograms be routine for women over 40? Chairperson: P.E. Schwartz, USA 1.. Do routine mammograms save lives? Why are there different recommendations if the data is similar? P. Neven, Belgium 2.. Breast cancer and pregnancy C. Markopoulos, Greece 3.. Chemoprevention for BRCA carriers? E. Goga, Greece 17:30 - 19:00 Hot Controversies Chairperson: N-O. Sjoberg, Sweden 1.. Gestational diabetes-treatment or over-treatment? K. Czajkowski, Poland 2.. Neonatal sepsis after single vs. multiple courses of antenatal betamethasone therapy S. Landolfo, Italy 3.. New objective methods for the continuous assessment of fetal activity K. Kaluzynski, Poland 4.. Angiogenesis in intrauterine growth restriction A. Malamitsi-Puchner, Greece 5.. Women’s views and preferences regarding three approaches to hospital care following first trimester miscarriage J. M. Shelley, Australia 6.. Modification of preterm uterine contractile activity by inflammation: should we combine anti-inflammatory drugs with anti-oxytocins? T. Laudanski, Poland 7.. Does antenatal iron efficiency anemia have an adverse effect on pregnancy outcome? T. T. Lao, Hong Kong Sunday, April 17, 2005 08:00 - 09:30 Thrombophilia in Obstetrics and Gynecology Capsule: Screening for Thrombophilia may be useful in preventing complications Chairperson: B. Brenner, Israel 1.. Thrombophilia 2005 - overview T. Hatzis, Greece 2.. Thrombophilia: what is the evidence for the relation with adverse pregnancy outcomes? B. Brenner, Israel 3.. The value of LMWH treatment in Ob/Gyn? D. Blickstein, Israel 09:30 - 10:00 Coffee Break 10:00 - 11:30 Emergency Cases in Pregnancy Capsule: Do we know how to effectively treat these emergency cases? Chairpersons: G. C. Di Renzo, Italy, Z. Hagay, Israel 1.. Abruption of placenta - which is the preferred way to deliver? 2.. Delivery of the impact fetal head: instrumental vs. CS I. Blickstein, Israel 3.. Uterine atony: what can be done before hysterectomy? R. Kalish, USA 11:30 - 13:00 New Technology and Technique Chairperson: C. Sen, Turkey 1.. Back to basics: the cardiotocograph made simple J. Gardosi, UK 2.. Evidence-based fetal testing: the case for condition-specific fetal testing A.M. Vintzileos, USA 3.. Methods of second trimester abortion S. Chasen, USA To remove your name from the OBGYN.net update service see: http://www.obgyn.net/english/forums/update.asp OBGYN.net, A service of MediSpecialty.com, Inc. 1 Richmond Street, Suite 4002 New Brunswick, NJ 08901
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Thu Oct 2 04:47:47 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.